Kantarama E

No ORCID on file · 1 paper in corpus
other 2025
Cardiometabolic Risk Marker Changes in Centrally Obese Women Using Depot Medroxyprogesterone Acetate (DMPA) in Kigali, Rwanda
Rwanda journal of medicine and health sciences ·doi:10.4314/rjmhs.v8i1.2

BACKGROUND: Hormonal contraceptives, such as depot medroxyprogesterone acetate (DMPA), are known to increase the risk of cardiometabolic disease, especially in obese users who are already at high risk. OBJECTIVES: This study aimed to evalu…